|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 828.70 INR | -2.57% |
|
-3.03% | +10.27% |
| 05-28 | Supriya Lifescience Limited, Q4 2026 Earnings Call, May 28, 2026 | |
| 05-27 | Supriya Lifescience Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 66.7B 693M 605M 559M 515M 970M 992M 6.68B 2.63B 32.67B 2.6B 2.54B 112B | P/E 2026 |
21.6x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 66.7B 693M 605M 559M 515M 970M 992M 6.68B 2.63B 32.67B 2.6B 2.54B 112B | EV / Sales 2026 |
5.46x | EV / Sales 2027 * | 6.71x |
| Free-Float |
28.72% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Supriya Lifescience Limited
| 1 day | -2.57% | ||
| 1 week | -3.03% | ||
| Current month | -18.60% | ||
| 1 month | -9.37% | ||
| 3 months | +29.79% | ||
| 6 months | +12.45% | ||
| Current year | +10.27% |
| 1 week | 816.1 |  | 875 |
| 1 month | 816.1 | | 1,043.2 |
| Current year | 545.5 | | 1,085 |
| 1 year | 545.5 | | 1,085 |
| 3 years | 233.3 | | 1,085 |
| 5 years | 170.15 | | 1,085 |
| 10 years | 170.15 | | 1,085 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 34 | 2024-07-31 | |
| Chief Executive Officer | 36 | 2024-07-31 | |
| Director of Finance/CFO | - | 2023-01-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2008-03-25 | |
| Director/Board Member | 41 | 2019-05-31 | |
| Director/Board Member | 36 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.57% | -3.03% | +15.05% | +237.28% | 693M | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,051B | |
| +1.23% | -1.53% | +55.26% | +59.07% | 609B | |
| +0.04% | +2.58% | +32.96% | +88.75% | 450B | |
| +0.78% | -0.71% | +30.04% | +24.61% | 330B | |
| +1.41% | +0.58% | +33.92% | +47.20% | 284B | |
| -0.27% | -1.87% | +22.13% | +23.47% | 263B | |
| -1.76% | +2.37% | -22.19% | -38.45% | 223B | |
| -1.42% | +0.80% | +22.81% | +60.77% | 198B | |
| -1.48% | +3.43% | +23.42% | +73.31% | 167B | |
| Average | -0.36% | +0.29% | +26.82% | +73.97% | 357.58B | |
| Weighted average by Cap. | +0.21% | +0.02% | +37.75% | +81.52% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 8.4B 87.23M 76.23M 70.34M 64.84M 122M 125M 841M 331M 4.11B 328M 320M 14.16B | 9.94B 103M 90.16M 83.19M 76.68M 145M 148M 994M 391M 4.87B 387M 379M 16.75B |
| Net income | 2B 20.78M 18.16M 16.76M 15.44M 29.11M 29.76M 200M 78.77M 980M 78.03M 76.32M 3.37B | 2.41B 25.02M 21.86M 20.17M 18.59M 35.05M 35.82M 241M 94.84M 1.18B 93.94M 91.88M 4.06B |
| Net Debt | - | - |
Employees
515
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | ₹828.70 | -2.57% | 266,098 |
| 26-07-16 | ₹850.60 | -0.21% | 123,732 |
| 26-07-15 | ₹852.40 | -2.10% | 116,682 |
| 26-07-14 | ₹870.70 | +3.04% | 344,442 |
| 26-07-13 | ₹845.00 | -1.12% | 218,343 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUPRIYA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
